用于膀胱癌检测与诊断的先进光学成像技术:系统综述
该系统综述评估了用于膀胱癌检测和诊断的先进光学成像技术,重点分析敏感性和特异性。检索MEDLINE、EMBASE和Web of Science至2023年11月21日,最终纳入52篇文献。所有检测技术的敏感性均高于白光膀胱镜,其中窄带成像(NBI)领先(87.8-100%);光动力诊断(PDD)特异性最高(23.3-100%)。光学相干断层扫描(OCT)对原位癌诊断特异性高(97-99%)。作者认为PDD用于检测、OCT用于分期分级最具潜力,需进一步研究验证其常规应用。
要点
- 所有检测技术敏感性均高于白光膀胱镜,NBI领先(87.8-100%)。
- 检测技术特异性与白光膀胱镜相当,PDD特异性最高(23.3-100%)。
- OCT对原位癌诊断特异性(97-99%)高于CLE(62.5-81.3%)。
核心结论
- 作者认为最具潜力的光学技术是PDD用于膀胱癌检测、OCT用于分期和分级。
- 作者指出需进一步研究以验证这些技术整合入常规实践,并探索其他成像技术的价值。
研究设计与样本
- 系统综述:先进行范围搜索确定所有可用于膀胱癌检测和诊断的光学技术,再系统检索MEDLINE、EMBASE和Web of Science自建库至2023年11月21日的文献。
- 由两名独立评价者筛选文献,纳入标准为报告特定技术的敏感性和特异性并与组织病理学比较,检测技术还需与白光膀胱镜比较。
- 从6707篇文献中,189篇进行全文审查,最终纳入52篇。
主要发现
- IMAGE1 S、PAI、SFE、拉曼光谱和细胞内镜均无文献符合纳入标准。
- 所有检测技术敏感性均高于白光膀胱镜,NBI领先(87.8-100%)。
- 检测技术总体特异性与白光膀胱镜相当,PDD特异性最高(23.3-100%)。
- CLE和OCT的敏感性和特异性各异,OCT对膀胱癌诊断特异性更高,尤其对原位癌(97-99%)对比CLE(62.5-81.3%)。
- NLO基于两项小型离体研究的有限数据显示高敏感性和特异性(分别为90-97%和77-100%)。
关键数值与推荐
- 检测技术敏感性:NBI 87.8-100%,所有检测技术均高于白光膀胱镜。
- 检测技术特异性:PDD最高(23.3-100%),总体与白光膀胱镜相当。
- OCT对原位癌诊断特异性97-99%,CLE为62.5-81.3%。
- NLO敏感性90-97%,特异性77-100%(基于两项小型离体研究)。
临床怎么用
- 作者认为PDD用于膀胱癌检测、OCT用于分期和分级最具潜力。
- 作者指出需进一步研究验证这些技术整合入常规实践,并探索其他成像技术的价值。
局限性
- IMAGE1 S、PAI、SFE、拉曼光谱和细胞内镜无文献符合纳入标准,无法评估。
- NLO数据基于两项小型离体研究的有限数据。
- 作者指出需进一步研究验证光学技术整合入常规实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically assess the current available literature concerning advanced optical imaging methods for the detection and diagnosis of bladder cancer (BCa), focusing particularly on the sensitivity and specificity of these techniques. METHODS: First a scoping search was performed to identify all available optical techniques for BCa detection and diagnosis. The optical imaging techniques used for detecting BCa are: the Storz professional image enhancement system (IMAGE1 S), narrow-band imaging (NBI), photoacoustic imaging (PAI), autofluorescence imaging (AFI), photodynamic diagnosis (PDD), and scanning fibre endoscopy (SFE). The staging and grading techniques for BCa are: optical coherence tomography (OCT), confocal laser endomicroscopy (CLE), Raman spectroscopy, endocytoscopy, and non-linear optical microscopy (NLO). Then a systematic literature search was conducted using MEDLINE, EMBASE and Web of Science from inception to 21 November 2023. Articles were screened and selected by two independent reviewers. Inclusion criteria were: reporting on both the sensitivity and specificity of a particular technique and comparison to histopathology, and in the case of a detection technique comparison to white light cystoscopy (WLC). RESULTS: Out of 6707 articles, 189 underwent full-text review, resulting in 52 inclusions. No articles met criteria for IMAGE1 S, PAI, SFE, Raman spectroscopy, and endocytoscopy. All detection techniques showed higher sensitivity than WLC, with NBI leading (87.8-100%). Overall, detection technique specificity was comparable to WLC, with PDD being most specific (23.3-100%). CLE and OCT varied in sensitivity and specificity, with OCT showing higher specificity for BCa diagnosis, notably for carcinoma in situ (97-99%) compared to CLE (62.5-81.3%). NLO demonstrated high sensitivity and specificity (90-97% and 77-100%, respectively) based on limited data from two small ex vivo studies. CONCLUSIONS: Optical techniques with the most potential are PDD for detecting and OCT for staging and grading BCa. Further research is crucial to validate their integration into routine practice and explore the value of other imaging techniques.
引用
- Remmelink MJ, Rip Y, Nieuwenhuijzen JA, et al. Advanced optical imaging techniques for bladder cancer detection and diagnosis: a systematic review. BJU Int. 2024. PMID: 39015996. doi:10.1111/bju.16471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。